The Central Drug Testing Laboratory in Karachi has officially obtained World Health Organization prequalification for its drug testing services, marking a significant milestone for laboratory standards in Pakistan. This recognition confirms that CDL Karachi meets international testing benchmarks required for reliable assessment of therapeutic products.
By aligning with WHO criteria, the Drug Regulatory Authority of Pakistan (DRAP) underscores its commitment to ensuring that medicines relied upon by families across the country are tested to global standards. The achievement further strengthens trust in Made in Pakistan pharmaceutical products by assuring accurate and honest testing practices.
DRAP CEO Dr. Ubaidullah congratulated the CDL team on this accomplishment and described it as an important step toward reinforcing the national regulatory system. The endorsement of CDL Karachi signals improved institutional capacity for quality control and regulatory oversight within Pakistan’s pharmaceutical sector.
The WHO prequalification of CDL Karachi is expected to bolster confidence among healthcare providers, patients and industry partners, while supporting the continued development of Pakistan’s testing infrastructure and credibility in regional and international markets.
